NFKB1 and COVID-19: In the case of COVID-19, an impaired type I interferon response associated with a persistent blood virus load and an exacerbated inflammatory response driven by NF-κB, particularly by increased TNF-α and IL-6 production, were observed in a cohort of fifty COVID-19 patients [109,110,111].